InvestorsHub Logo
Followers 14
Posts 898
Boards Moderated 0
Alias Born 03/07/2011

Re: Double_Bagel post# 12838

Wednesday, 12/17/2014 9:12:32 AM

Wednesday, December 17, 2014 9:12:32 AM

Post# of 20689

HALO and MNTA are two of the most disappointing biotech stocks ever



Let us see if today's HALO news is enough to get HALO out of the 7s. Probably not. Hopefully, they end in the green today smile

------------
Halozyme Therapeutics Enters A Global Collaboration With Janssen To Develop And Commercialize Subcutaneous Products Using ENHANZE™ Technology

http://seekingalpha.com/pr/12017105-halozyme-therapeutics-enters-a-global-collaboration-with-janssen-to-develop-and-commercialize-subcutaneous-products-using-enhanze-technology

"We are pleased that Janssen, a global leader in the development of novel therapeutics, has selected our ENHANZE technology to further augment their development pipeline," said Dr. Helen Torley, President and Chief Executive Officer. "This new global licensing agreement further validates our ENHANZE platform technology, which we believe may benefit a growing number of patients worldwide by making therapies more convenient."

Under the terms of the agreement, Halozyme has granted to Janssen a worldwide license to develop and commercialize products for up to five targets combining rHuPH20 with Janssen's proprietary compounds. Halozyme will receive an initial payment of $15 million, and is eligible to receive additional payments upon Janssen's achievement of specified development, regulatory and sales-based milestones, totaling up to $566 million. Halozyme is also entitled to royalty payments based on net sales of products using the ENHANZE technology.